Physician profile
Aaron H Smith
NPI 1033614821
$7,826.49
in general payments reported to CMS, 2019-2025
12 companies · $604 in 2025
The $604 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,413 · 2023: $4,762 · 2024: $1,046 · 2025: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,566 · Food and Beverage: $2,847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,566.35 |
| Food and Beverage | $2,846.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,309.15 | 2023 | Proclaim |
| Medtronic, INC. | $1,395.93 | 2022-2024 | Intellis Adaptivestim |
| Nevro Corp. | $484.97 | 2022-2024 | Senza |
| Boston Scientific Corporation | $451.58 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $397.71 | 2023-2025 | Relistor, Trulance |
| Collegium Pharmaceutical, INC. | $275.17 | 2023-2025 | Xtampza, Belbuca |
| Globus Medical, INC. | $205.41 | 2025 | Senza |
| Abbvie INC. | $204.61 | 2023-2025 | Ubrelvy |
| Pfizer INC. | $33.28 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $31.37 | 2025 | |
| Averitas Pharma INC. | $20.47 | 2024 | Qutenza |
| Idorsia Pharmaceuticals US INC | $16.84 | 2024 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.